Improving genetic programming for the prediction of pharmacokinetic parameters

被引:0
作者
Leonardo Vanneschi
机构
[1] Universidade Nova de Lisboa,ISEGI
来源
Memetic Computing | 2014年 / 6卷
关键词
Genetic programming; Drug discovery; Pharmacokinetics ; Bioavailability; Toxicity; Protein binding level;
D O I
暂无
中图分类号
学科分类号
摘要
The prediction of pharmacokinetic parameters is a crucial phase of the drug discovery process, and the automatization of this task is a hot topic in computational bio-medicine. In the last 10 years, a significant amount of research has been published reporting on applications of genetic programming to the prediction of pharmacokinetic parameters. This paper summarizes and discusses some of those contributions. In particular, the focus is on the idea that pharmacokinetic problems are so complex that the “canonic” version of genetic programming is often not able to perform appropriately on them. At the same time, genetic programming has a high degree of versatility, given by the opportunity it offers of adapting many crucial parts of its algorithm, among which the fitness function and the employed genetic operators. This gives us the chance to improve standard genetic programming in several different ways. For instance, sophisticated fitness functions, methods to control bloat and operators to exploit the geometry of the semantic space are discussed here.
引用
收藏
页码:255 / 262
页数:7
相关论文
共 19 条
[1]  
Tuffs A(2001)Bayer faces shake up after Lipobay withdrawn Br Med J 323 828-432
[2]  
Archetti F(2007)Genetic programming for computational pharmacokinetics in drug discovery and development Genet Program Evol Mach 8 413-2585
[3]  
Lanzeni S(2000)QSAR model for drug human oral bioavailability J Med Chem 43 2575-204
[4]  
Messina E(2003)ADMET in silico modeling: towards prediction paradise? Nat Rev Drug Discov 2 192-716
[5]  
Vanneschi L(2004)Can the pharmaceutical industry reduce attrition rates? Nat Rev Dug Discov 3 711-414
[6]  
Yoshida F(2000)ADME/PK as part of a rational approach to drug discovery Drug Discov Today 9 409-601
[7]  
Topliss JG(2012)Bloat free genetic programming: application to human oral bioavailability prediction Int J Data Min Bioinform 6 585-444
[8]  
van de Waterbeemd H(1997)Managing the drug discovery/development interface Drug Discov Today 2 436-937
[9]  
Gifford E(2006)Prediction of ADMET properties Chem Med Chem 1 920-undefined
[10]  
Kola I(undefined)undefined undefined undefined undefined-undefined